ClinicalTrialsFinder

Ovarian Carcinoma, Recurrent Clinical Trials in Seoul, Seoul

1 recruitingSeoul, Seoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 2

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Ovarian CancerOvarian Cancer Metastatic RecurrentOvarian Cancer (OvCa)+1 more
Yonsei University116 enrolled1 locationNCT07340164